Size and temporal-dependent efficacy of oltipraz-loaded PLGA nanoparticles for treatment of acute kidney injury and fibrosis

Hoste, 2018, Global epidemiology and outcomes of acute kidney injury, Nat. Rev. Nephrol., 14, 607, 10.1038/s41581-018-0052-0 Zuk, 2016, Acute kidney injury, Annu. Rev. Med., 67, 293, 10.1146/annurev-med-050214-013407 Lameire, 2013, Acute kidney injury: an increasing global concern, Lancet, 382, 170, 10.1016/S0140-6736(13)60647-9 Hoste, 2015, Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study, Intensive Care Med., 41, 1411, 10.1007/s00134-015-3934-7 Ferenbach, 2015, Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD, Nat. Rev. Nephrol., 11, 264, 10.1038/nrneph.2015.3 Matejovic, 2016, Renal hemodynamics in AKI: in search of new treatment targets, J. Am. Soc. Nephrol., 27, 49, 10.1681/ASN.2015030234 Liu, 2018, Renal tubule injury: a driving force toward chronic kidney disease, Kidney Int., 93, 568, 10.1016/j.kint.2017.09.033 Leung, 2013, Chronic kidney disease following acute kidney injury-risk and outcomes, Nat. Rev. Nephrol., 9, 77, 10.1038/nrneph.2012.280 Sharif, 2016, The global nephrology workforce: emerging threats and potential solutions!, Clin. Kidney J., 9, 11, 10.1093/ckj/sfv111 Kamaly, 2016, Nanomedicines for renal disease: current status and future applications, Nat. Rev. Nephrol., 12, 738, 10.1038/nrneph.2016.156 Williams, 2016, Nanomedicines for kidney diseases, Kidney Int., 90, 740, 10.1016/j.kint.2016.03.041 Tietjen, 2017, Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys, Sci. Transl. Med., 9, 10.1126/scitranslmed.aam6764 Wang, 2017, Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease, Biomater. Sci., 5, 1450, 10.1039/C7BM00271H Williams, 2015, Mesoscale nanoparticles selectively target the renal proximal tubule epithelium, Nano Lett., 15, 2358, 10.1021/nl504610d Gao, 2014, Megalin-mediated specific uptake of chitosan/siRNA nanoparticles in mouse kidney proximal tubule epithelial cells enables AQP1 gene silencing, Theranostics, 4, 1039, 10.7150/thno.7866 Lawrence, 2017, Permeation of macromolecules into the renal glomerular basement membrane and capture by the tubules, Proc. Natl. Acad. Sci. U. S. A., 114, 2958, 10.1073/pnas.1616457114 von Roemeling, 2017, Breaking down the barriers to precision cancer nanomedicine, Trends Biotechnol., 35, 159, 10.1016/j.tibtech.2016.07.006 Satchell, 2013, The role of the glomerular endothelium in albumin handling, Nat. Rev. Nephrol., 9, 717, 10.1038/nrneph.2013.197 Alidori, 2016, Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury, Sci. Transl. Med., 8, 331, 10.1126/scitranslmed.aac9647 Qiao, 2014, Kidney-specific drug delivery system for renal fibrosis based on coordination-driven assembly of catechol-derived chitosan, Biomaterials, 35, 7157, 10.1016/j.biomaterials.2014.04.106 Jiang, 2018, DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury, Nat. Biomed. Eng., 2, 865, 10.1038/s41551-018-0317-8 Malek, 2015, Renal ischemia/reperfusion injury; from pathophysiology to treatment, J. Ren. Inj. Prev., 4, 20 Andersson, 2007, Mild renal ischemia-reperfusion reduces charge and size selectivity of the glomerular barrier, Am. J. Physiol. Renal. Physiol., 292, 1802, 10.1152/ajprenal.00152.2006 Tyritzis, 2011, Effects of prolonged warm and cold ischemia in a solitary kidney animal model after partial nephrectomy: an ultrastructural investigation, Ultrastruct. Pathol., 35, 60, 10.3109/01913123.2010.542880 Rippe, 2006, Nature of glomerular capillary permeability changes following acute renal ischemia-reperfusion injury in rats, Am. J. Physiol. Renal. Physiol., 291, 1362, 10.1152/ajprenal.00123.2006 Shelton, 2013, Role of Nrf2 in protection against acute kidney injury, Kidney Int., 84, 1090, 10.1038/ki.2013.248 Nezu, 2017, Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression, Kidney Int., 91, 387, 10.1016/j.kint.2016.08.023 Ruiz, 2013, Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease, Kidney Int., 83, 1029, 10.1038/ki.2012.439 Chan, 2009, PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery, Biomaterials, 30, 1627, 10.1016/j.biomaterials.2008.12.013 Zhang, 2008, Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform, ACS Nano, 2, 1696, 10.1021/nn800275r Tampe, 2017, Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progression, Kidney Int., 91, 157, 10.1016/j.kint.2016.07.042 Ge, 2018, GCN2 is a potential prognostic biomarker for human papillary renal cell carcinoma, Cancer Biomark., 22, 395, 10.3233/CBM-170922 Yuste, 2015, Pathogenesis of glomerular haematuria, World J. Nephrol., 4, 185, 10.5527/wjn.v4.i2.185 Castrop, 2017, Novel routes of albumin passage across the glomerular filtration barrier, Acta Physiol., 219, 544, 10.1111/apha.12760 Wang, 2009, Segment-specific expression of netrin-1 receptors in normal and ischemic mouse kidney, Am. J. Nephrol., 30, 186, 10.1159/000213503 Ma, 2013, Role of nrf2 in oxidative stress and toxicity, Annu. Rev. Pharmacol. Toxicol., 53, 401, 10.1146/annurev-pharmtox-011112-140320 Joo, 2013, miR-125b transcriptionally increased by Nrf2 inhibits AhR repressor, which protects kidney from cisplatin-induced injury, Cell Death Dis., 4, e899, 10.1038/cddis.2013.427 Atilano-Roque, 2016, Nrf2 activators as potential modulators of injury in human kidney cells, Toxicol Rep, 3, 153, 10.1016/j.toxrep.2016.01.006 Kong, 2018, Nrf2 deficiency promotes the progression from acute tubular damage to chronic renal fibrosis following unilateral ureteral obstruction, Nephrol. Dial. Transplant., 33, 771, 10.1093/ndt/gfx299 Moeller, 2013, Renal albumin filtration: alternative models to the standard physical barriers, Nat. Rev. Nephrol., 9, 266, 10.1038/nrneph.2013.58 Liu, 2014, The Nrf2 triterpenoid activator, CDDO-imidazolide, protects kidneys from ischemia-reperfusion injury in mice, Kidney Int., 85, 134, 10.1038/ki.2013.357